Ludovic Ménard

1.1k total citations
15 papers, 786 citations indexed

About

Ludovic Ménard is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Ludovic Ménard has authored 15 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Ludovic Ménard's work include Liver physiology and pathology (5 papers), Ubiquitin and proteasome pathways (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Ludovic Ménard is often cited by papers focused on Liver physiology and pathology (5 papers), Ubiquitin and proteasome pathways (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Ludovic Ménard collaborates with scholars based in United Kingdom, France and United States. Ludovic Ménard's co-authors include Stéphanie Kermorgant, Carine Joffre, Ian R. Hart, Véronique Calleja, Peter J. Parker, Jean Rosenbaum, Danièle Taras, Valérie Haurie, Alexandra Nicou and Otmar Huber and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Nature Cell Biology.

In The Last Decade

Ludovic Ménard

14 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ludovic Ménard United Kingdom	10	536	235	167	136	110	15	786
Gaynor Davies United Kingdom	19	576 1.1×	351 1.5×	107 0.6×	99 0.7×	203 1.8×	22	1.0k
Zoulika Kherrouche France	19	601 1.1×	267 1.1×	63 0.4×	284 2.1×	255 2.3×	36	1.0k
Michaela Herzig Austria	10	816 1.5×	457 1.9×	172 1.0×	89 0.7×	37 0.3×	10	1.2k
Lene Melsæther Grøvdal Denmark	11	560 1.0×	361 1.5×	236 1.4×	98 0.7×	21 0.2×	13	893
Margit Hagel United States	9	598 1.1×	104 0.4×	280 1.7×	52 0.4×	64 0.6×	14	890
So-I Shin Japan	9	610 1.1×	262 1.1×	121 0.7×	27 0.2×	183 1.7×	16	785
Valentina A. Schmidt United States	16	588 1.1×	136 0.6×	212 1.3×	43 0.3×	54 0.5×	24	1.1k
Kathleen A. Scorsone United States	15	674 1.3×	350 1.5×	153 0.9×	63 0.5×	39 0.4×	18	1.0k
Cristina Basilico Italy	17	669 1.2×	352 1.5×	107 0.6×	144 1.1×	679 6.2×	31	1.3k
Sze Hang Lau Hong Kong	9	351 0.7×	176 0.7×	88 0.5×	51 0.4×	156 1.4×	9	693

Countries citing papers authored by Ludovic Ménard

Since Specialization

Citations

This map shows the geographic impact of Ludovic Ménard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovic Ménard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovic Ménard more than expected).

Fields of papers citing papers by Ludovic Ménard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovic Ménard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovic Ménard. The network helps show where Ludovic Ménard may publish in the future.

Co-authorship network of co-authors of Ludovic Ménard

This figure shows the co-authorship network connecting the top 25 collaborators of Ludovic Ménard. A scholar is included among the top collaborators of Ludovic Ménard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludovic Ménard. Ludovic Ménard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hervieu, Alexia, Chi Zhang, Rachel Barrow‐McGee, et al.. (2020). A PI3K- and GTPase-independent Rac1-mTOR mechanism mediates MET-driven anchorage-independent cell growth but not migration. Science Signaling. 13(637). 15 indexed citations

Floc’h, Nicolas, Matthew J. Martin, Jonathan W. Riess, et al.. (2018). Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions. Molecular Cancer Therapeutics. 17(5). 885–896. 85 indexed citations

Ménard, Ludovic, Nicolas Floc’h, Matthew J. Martin, & Darren A.E. Cross. (2018). Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors. Cancer Research. 78(12). 3267–3279. 33 indexed citations

Xiao, Malina, Muhammad Zaeem Noman, Ludovic Ménard, et al.. (2018). Driving Cytotoxic Natural Killer Cells into Melanoma: If CCL5 Plays the Music, Autophagy Calls the Shots. Critical Reviews™ in Oncogenesis. 23(5-6). 321–332. 5 indexed citations

Powles, Thomas, et al.. (2017). Understanding and targeting Met signalling in bladder cancer. Annals of Oncology. 28. v16–v16.

Riess, Jonathan W., Nicolas Floc’h, Matthew W. Martin, et al.. (2017). Antitumor activity of osimertinib in NSCLC harboring EGFR exon 20 insertions.. Journal of Clinical Oncology. 35(15_suppl). 9030–9030. 5 indexed citations

Barrow‐McGee, Rachel, Carine Joffre, Ludovic Ménard, et al.. (2016). Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes. Nature Communications. 7(1). 11942–11942. 89 indexed citations

Ward, Richard A., S. Ashton, A R Bianco, et al.. (2016). Osimertinib (AZD9291), an irreversible 3rd generation TKI, induces tumor growth inhibition in NSCLC pre-clinical models harboring the most prevalent EGFR Ex20Ins (in vitro and in vivo). European Journal of Cancer. 69. S39–S39. 1 indexed citations

Ménard, Ludovic, Peter J. Parker, & Stéphanie Kermorgant. (2014). Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways. Nature Communications. 5(1). 3907–3907. 81 indexed citations

10.

Joffre, Carine, et al.. (2014). Measuring the Role for Met Endosomal Signaling in Tumorigenesis. Methods in enzymology on CD-ROM/Methods in enzymology. 535. 121–140. 4 indexed citations

11.

Joffre, Carine, et al.. (2011). A direct role for Met endocytosis in tumorigenesis. Nature Cell Biology. 13(7). 827–837. 196 indexed citations

12.

Ménard, Ludovic, Danièle Taras, Valérie Haurie, et al.. (2010). In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence. Journal of Hepatology. 52(5). 681–689. 46 indexed citations

13.

Haurie, Valérie, Ludovic Ménard, Alexandra Nicou, et al.. (2009). Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism†. Hepatology. 50(6). 1871–1883. 54 indexed citations

14.

Huber, Otmar, Ludovic Ménard, Valérie Haurie, et al.. (2008). Pontin and Reptin, Two Related ATPases with Multiple Roles in Cancer. Cancer Research. 68(17). 6873–6876. 82 indexed citations

15.

Rousseau, Benoı̂t, Ludovic Ménard, Valérie Haurie, et al.. (2007). Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology. 46(4). 1108–1118. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact